Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin as an Inflammatory Modulating Therapy in Older Adults Without Diabetes
NCT03772964Phase 2Completed
- Start
- Jan 2019
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liquid metformin (Aspargo Labs) in inflammation. Started Jan 2019; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
inflammation
Beyond the preview
Go deeper on NCT03772964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03772964.